NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy
ACS Applied Materials & Interfaces · 2024-08-14 · 16 (32) · 41916-41926
DOI: 10.1021/acsami.4c09211 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2024-07-31. Written by Xing Guo and 8 co-authors. Institution: The Key Laboratory of Functional Molecular Solids, Ministry of Education; Anhui Province Key Laboratory of Biomedical Materials and Chemical Measurem…. Major MEDLINE topics: Lysosomes, Photosensitizing Agents, Nanoparticles. Cited 28 times so far (Crossref); 68 references. Funded by: Anhui Provincial Department of Education, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (original language)
Photosensitizer-based phototherapies, including photodynamic therapy (PDT) and photothermal therapy (PTT), offer safe treatment modalities for tumor ablation with spatiotemporal precision. After photons are absorbed, PDT creates localized chemical damage by generating reactive oxygen species (ROS), while PTT induces localized thermal damage. However, PDT still faces hypoxic tumor challenges, while PTT encounters issues related to heat resistance and potential overheating. The combination of PDT and PTT shows great potential as an effective anticancer strategy. By targeting lysosomes with carefully designed phototherapeutic reagents for combined phototherapy, rapid dysfunction and cell death in cancer cells can be induced, showing promise for cancer treatment. Herein, two α-α-linked bisBODIPYs with tetraphenylethene (TPE) moieties are designed and synthesized. These TPE-substituted bisBODIPYs expand the absorption into NIR range (λmaxabs/λmaxem ∼ 740/810 nm) and confer aggregation-induced emission (AIE) activity (λmaxem ∼ 912 nm). Moreover, these bisBODIPYs self-assemble with surfactant F-127 into nanoparticles (NPs), which efficiently generate ROS (1O2 and •OH) in both solution and cellular environments and demonstrate superior photothermal conversion efficiencies (η ∼ 68.3%) along with exceptional photothermal stability. More importantly, these NPs showed lysosomal targeting and remarkable tumor ablation in cellular and murine models, indicating their potential in precision tumor therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Key Laboratory of Functional Molecular Solids, Ministry of Education; Anhui Province Key Laboratory of Biomedical Materials and Chemical Measurement, School of Chemistry and Materials Science, Anhui Normal Universit…
- The Translational Research Institute for Neurological Disorders, Department of Neurosurgery; The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu 241001, China.
ORCID profiles: Qinghua Wu, Lijuan Jiao, Erhong Hao
Funding
- Anhui Provincial Department of Education
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
Cite
APA
Guo, X., Tang, B., Wu, Q., Zhong, W., Gong, Q., Ling, S., Jiao, L., Jiang, X., & Hao, E. (2024). NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy. ACS Applied Materials & Interfaces, 16(32), 41916-41926. https://doi.org/10.1021/acsami.4c09211
Vancouver
Guo X, Tang B, Wu Q, Zhong W, Gong Q, Ling S, et al. NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy. ACS Applied Materials & Interfaces. 2024;16(32):41916-41926. doi:10.1021/acsami.4c09211
BibTeX
@article{Guo2024,
author = {Guo, Xing and Tang, Bing and Wu, Qinghua and Zhong, Wenhua and Gong, Qingbao and Ling, Shizhang and Jiao, Lijuan and Jiang, Xiaochun and Hao, Erhong},
title = {NIR-Absorbing Tetraphenylethene-Containing bisBODIPY Nanoplatforms Demonstrate Effective Lysosome-Targeting and Combinational Phototherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {32},
pages = {41916--41926},
doi = {10.1021/acsami.4c09211}
}
EUVIMED